Reimbursement and payor policy risk
Clinic and treatment-session demand depend on Medicare, managed care, and commercial coverage.
- Scope
- U.S. psychiatric treatment reimbursement
- Materiality
- high
Neuronetics, Inc.
Neuronetics, Inc. develops and commercializes NeuroStar Advanced Therapy System, a non-invasive medical device used in psychiatric care, along with recurring treatment-session access codes and related services. The company is based in the United States and sells primarily to psychiatrists and psychiatric practices, with a small international distribution footprint.
−18,8 %
48,5 %
−26,1 %
+99,2 %
2.02
1.87
| % | |
|---|---|
| NeuroStar system sales and rentals | 9% Capital equipment sales, rentals, upgrades, and related hardware for the NeuroStar platform. |
| Treatment sessions | 30% Recurring access codes and treatment-session revenue used with the NeuroStar system. |
| Clinic revenue | 60% Revenue from treatments performed in company-operated or affiliated clinic settings. |
| Other revenue | 1% Service, repair, research collaboration, and extended warranty revenue. |
Neuronetics sells to psychiatrists, group psychiatric practices, and treatment centers that use NeuroStar to treat...
- Psychiatrists and psychiatric practicesprimary
Buy NeuroStar systems and treatment-session access to treat MDD patients in-office and generate recurring patient revenue.
- Clinic operatorsprimary
Operate treatment sites and earn clinic revenue from performed sessions and patient fees.
- Third-party payorsprimary
Medicare, managed care, and commercial insurers reimburse treatments and influence utilization.
- International distributorssecondary
Purchase and distribute products in select non-U.S. markets.
The business is overwhelmingly U.S.-centric, with the United States accounting for 98% of revenue in the nine months...
- •United States is the core market and main revenue source
- •International sales are small and distributor-based
- •Clinic revenue is tied to treatment activity in 15 U.S. states
- •Manufacturing components are outsourced, with final handling in Pennsylvania
- •U.S. reimbursement dynamics are central to demand
Neuronetics is focused on expanding adoption of NeuroStar through direct sales coverage, customer support, and clinical...
01
Expand installed base and utilizationshort-term
More systems in the field and higher session volume increase recurring revenue opportunities.
02
Develop additional indicationsmedium-term
Broader clinical use can expand the addressable market and support adoption.
03
Scale clinic revenuemedium-term
Clinic operations add a direct patient-fee stream and deepen market penetration.
Neuronetics depends on reimbursement, physician adoption, and patient willingness to pursue treatment, so demand can be...
Manufacturing and supply chain risk
Components are produced by third-party contract manufacturers and assembled through outsourced partners.
- Scope
- Component availability, cost, and quality
- Materiality
- high
Product concentration risk
The business is centered on NeuroStar and related treatment-session revenue.
- Scope
- Single-platform dependence
- Materiality
- high
Liquidity and covenant risk
Borrowings under the Perceptive Facility include revenue and liquidity covenants.
- Scope
- Debt compliance and financing flexibility
- Materiality
- high
Macroeconomic demand sensitivity
Patients may delay or forego medical services during weaker economic conditions.
- Scope
- Consumer and provider spending on psychiatric care
- Materiality
- medium
Clinic revenue estimation
Can materially affect reported revenue and receivables
Variable consideration
Creates estimation uncertainty in clinic revenue
Multiple revenue streams
Affects revenue mix and comparability across periods
Warranty and service contracts
Influences deferred revenue and service-cost estimates
NEUROONE MEDICAL TECHNOLOGIES Corp
NMTC · Surgical & Medical Instruments & Apparatus
NeuroOne Medical Technologies develops and commercializes minimally invasive neurosurgical devices for diagnosing and treating brain and pain disorders.
NEUROCRINE BIOSCIENCES INC
NBIX · Biological Products, (No Diagnostic Substances)
Neurocrine Biosciences is a U.S.-based biopharmaceutical company focused on neuroscience and related endocrine disorders.
Neuraxis, INC
NRXS · Electromedical & Electrotherapeutic Apparatus
Neuraxis, INC is a U.S.-based medical device company focused on neuromodulation therapies for pediatric and adult patients.
ORAGENICS INC
OGEN · Pharmaceutical Preparations
DYADIC INTERNATIONAL INC
DYAI · Biological Products, (No Diagnostic Substances)
Dyadic International is a U.S.-based biotechnology platform company that develops microbial protein production systems for industrial, life sciences, food and…
Enveric Biosciences, Inc.
ENVB · Pharmaceutical Preparations
: 29.4.2026